NCT04486885View on ClinicalTrials.gov

European Study of Cerebral Aspergillosis Treated With Isavuconazole

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

August 1, 2022

Study Completion Date

March 1, 2023

Conditions
Cerebral AspergillosisInvasive Aspergillosis
Trial Locations (1)

75015

Hôpital Necker-Enfants Malades, Paris

Sponsors

Lead Sponsor

Imagine Institute
All Listed Sponsors
lead

Imagine Institute

OTHER